Cyclophosphamide vs melphalan in treatment of plasma cell myeloma.
D000328:Adult; D000368:Aged; D001536:Bence Jones Protein / Q000097:blood / Q000652:urine; D001797:Blood Protein Electrophoresis; D001806:Blood Urea Nitrogen; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use*; D006400:Hematocrit; D006801:Humans; D008297:Male; D008558:Melphalan / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000401:mortality; D010919:Placebos; D010950:Plasma Cells; D013921:Thrombocytopenia / Q000139:chemically induced; D005719:gamma-Globulins / Q000032:analysis
D010919:Placebos; D005719:gamma-Globulins; D003520:Cyclophosphamide; D001536:Bence Jones Protein; D008558:Melphalan